CARLSMED, INC. Overview
Latest ROE for CARLSMED, INC.: -43.83% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-43.83%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for CARL is -43.83%. That is below the sector sector average of 11.73%. Investors often review this figure alongside CARLSMED, INC.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, CARL currently prints -43.83% for ROE, while the sector average sits near 11.73%. That is roughly 473.6% below the sector mean. Large gaps often invite a closer look at CARLSMED, INC.'s growth, margins, and balance sheet.
Return on Equity shows how effectively CARLSMED, INC. converts resources into returns. At -43.83%, CARL may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CARL's ROE (-43.83%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
